Aurobindo Pharma has received tentative approval to manufacture and market AIDS drug Abacavir Sulfate / Lamivudine in the United States.
The product has been reviewed under the President's Emergency Plan for AIDS Relief (PEPFAR), which permits US Food and Drugs Administration to evaluate the quality of low cost versions of patented medicines for supply to government supported AIDS relief programmes.
This is the 76th marketing approval for Aurobindo in the United States, company informed Bombay Stock Exchange today.